Analyst Research

Report Title Price
Thomson Reuters Stock Report - SK CHEMICALS COMPANY LIMITED (006120-SE)
Provider: Thomson Reuters Stock Report
$25.00
Buy
SK Chemicals Co., Ltd. (006120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
SK Chemicals Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for SK Chemicals Company Limited
Provider: Wright Reports
$483.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

SK Chemicals Co., Ltd. to Merge with Subsidiary


Friday, 16 Dec 2011 02:06am EST 

SK Chemicals Co., Ltd. announced that it will merge with its wholly owned subsidiary, which is mainly engaged in the sale of CACP, to create synergy and improve operating efficiency. The merger effective date is February 20, 2012. 

Latest Developments for SK Chemicals Co Ltd

Latest Key Developments in Chemicals

Company Quote

SK Chemicals Co Ltd
(006120.KS)
43050.0
-1400.0 -3.15%
24 May 2013